888 related articles for article (PubMed ID: 12579570)
21. Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells.
Nonomura N; Lu J; Tanaka A; Yamanishi H; Sato B; Sonoda T; Matsumoto K
Cancer Res; 1990 Apr; 50(8):2316-21. PubMed ID: 2156616
[TBL] [Abstract][Full Text] [Related]
22. Controlled release of vascular endothelial growth factor from alginate hydrogels nano-coated with polyelectrolyte multilayer films.
Matsusaki M; Sakaguchi H; Serizawa T; Akashi M
J Biomater Sci Polym Ed; 2007; 18(6):775-83. PubMed ID: 17623557
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and pH sensitivity of carboxymethyl chitosan-based polyampholyte hydrogels for protein carrier matrices.
Chen L; Tian Z; Du Y
Biomaterials; 2004 Aug; 25(17):3725-32. PubMed ID: 15020148
[TBL] [Abstract][Full Text] [Related]
24. Disulfide-crosslinked chitosan hydrogel for cell viability and controlled protein release.
Wu ZM; Zhang XG; Zheng C; Li CX; Zhang SM; Dong RN; Yu DM
Eur J Pharm Sci; 2009 Jun; 37(3-4):198-206. PubMed ID: 19491006
[TBL] [Abstract][Full Text] [Related]
25. Photocrosslinkable chitosan hydrogel can prevent bone formation in both rat skull and fibula bone defects.
Tsuda Y; Ishihara M; Amako M; Arino H; Hattori H; Kanatani Y; Yura H; Nemoto K
Artif Organs; 2009 Jan; 33(1):74-7. PubMed ID: 19178444
[TBL] [Abstract][Full Text] [Related]
26. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process.
Ishihara M; Nakanishi K; Ono K; Sato M; Kikuchi M; Saito Y; Yura H; Matsui T; Hattori H; Uenoyama M; Kurita A
Biomaterials; 2002 Feb; 23(3):833-40. PubMed ID: 11771703
[TBL] [Abstract][Full Text] [Related]
27. New aspects of the formation of physical hydrogels of chitosan in a hydroalcoholic medium.
Boucard N; Viton C; Domard A
Biomacromolecules; 2005; 6(6):3227-37. PubMed ID: 16283750
[TBL] [Abstract][Full Text] [Related]
28. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM
J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837
[TBL] [Abstract][Full Text] [Related]
29. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells.
Moscatelli D
J Cell Physiol; 1987 Apr; 131(1):123-30. PubMed ID: 3032990
[TBL] [Abstract][Full Text] [Related]
30. Chitosan-polyvinyl pyrrolidone hydrogel does not activate macrophages: potentials for transplantation applications.
Risbud M; Bhonde M; Bhonde R
Cell Transplant; 2001; 10(2):195-202. PubMed ID: 11332634
[TBL] [Abstract][Full Text] [Related]
31. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis.
Zieris A; Prokoph S; Levental KR; Welzel PB; Grimmer M; Freudenberg U; Werner C
Biomaterials; 2010 Nov; 31(31):7985-94. PubMed ID: 20674970
[TBL] [Abstract][Full Text] [Related]
32. Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(gamma-glutamic acid)-sulfonate matrix for tissue engineering.
Matsusaki M; Akashi M
Biomacromolecules; 2005; 6(6):3351-6. PubMed ID: 16283765
[TBL] [Abstract][Full Text] [Related]
33. Ultraviolet light-irradiated photocrosslinkable chitosan hydrogel to prevent bone formation in both rat skull and fibula bone defects.
Tsuda Y; Hattori H; Tanaka Y; Ishihara M; Kishimoto S; Amako M; Arino H; Nemoto K
J Tissue Eng Regen Med; 2013 Sep; 7(9):720-8. PubMed ID: 22408001
[TBL] [Abstract][Full Text] [Related]
34. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.
Matsui M; Tabata Y
Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581
[TBL] [Abstract][Full Text] [Related]
35. Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2).
Princz MA; Sheardown H
J Biomater Sci Polym Ed; 2008; 19(9):1201-18. PubMed ID: 18727861
[TBL] [Abstract][Full Text] [Related]
36. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
Norton LW; Tegnell E; Toporek SS; Reichert WM
Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
[TBL] [Abstract][Full Text] [Related]
37. Photocrosslinkable chitosan as a biological adhesive.
Ono K; Saito Y; Yura H; Ishikawa K; Kurita A; Akaike T; Ishihara M
J Biomed Mater Res; 2000 Feb; 49(2):289-95. PubMed ID: 10571917
[TBL] [Abstract][Full Text] [Related]
38. Fabrication of chondroitin sulfate-chitosan composite artificial extracellular matrix for stabilization of fibroblast growth factor.
Mi FL; Shyu SS; Peng CK; Wu YB; Sung HW; Wang PS; Huang CC
J Biomed Mater Res A; 2006 Jan; 76(1):1-15. PubMed ID: 16224775
[TBL] [Abstract][Full Text] [Related]
39. Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy.
Saito T; Tabata Y
Acta Biomater; 2012 Feb; 8(2):646-52. PubMed ID: 22079782
[TBL] [Abstract][Full Text] [Related]
40. Novel functional biodegradable polymer. III. The construction of poly(gamma-glutamic acid)-sulfonate hydrogel with fibroblast growth factor-2 activity.
Matsusaki M; Serizawa T; Kishida A; Akashi M
J Biomed Mater Res A; 2005 Jun; 73(4):485-91. PubMed ID: 15900608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]